110 related articles for article (PubMed ID: 1970789)
1. Synergistic inhibitory effects of adrenoceptor antagonists and prostacyclin, and umbilical artery-derived prostacyclin-like activity on platelet aggregation.
Greer IA; McLaren M; Forbes CD
Eur J Obstet Gynecol Reprod Biol; 1990; 35(2-3):109-18. PubMed ID: 1970789
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of platelet aggregation in whole blood by adrenoceptor antagonists.
Greer IA; Walker JJ; Calder AA; Forbes CD
Thromb Res; 1985 Dec; 40(5):631-43. PubMed ID: 3937284
[TBL] [Abstract][Full Text] [Related]
3. A comparative study of the effects of adrenoceptor antagonists on platelet aggregation and thromboxane generation.
Greer IA; Walker JJ; McLaren M; Calder AA; Forbes CD
Thromb Haemost; 1985 Aug; 54(2):480-4. PubMed ID: 2867620
[TBL] [Abstract][Full Text] [Related]
4. Endothelial prostacyclin production, synergistic effect between adrenergic stimulating and blocking drugs.
Rydholm H; Boström S; Hansson G; Risberg B
Thromb Res; 1994 Nov; 76(4):333-41. PubMed ID: 7532874
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of thromboxane and prostacyclin production in whole blood by adrenoceptor antagonists.
Greer IA; Walker JJ; McLaren M; Calder AA; Forbes CD
Prostaglandins Leukot Med; 1985 Sep; 19(3):209-17. PubMed ID: 2865745
[TBL] [Abstract][Full Text] [Related]
6. Effects of prostacyclin on fetal platelet function.
Matsumoto T; Kihira M; Ito M; Sugiyama Y
Biol Res Pregnancy Perinatol; 1984; 5(1):11-5. PubMed ID: 6322874
[TBL] [Abstract][Full Text] [Related]
7. Enhancement of the antiaggregatory activity of prostacyclin by propranolol in human platelets.
Callahan KS; Johnson AR; Campbell WB
Circulation; 1985 Jun; 71(6):1237-46. PubMed ID: 2986877
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of platelet aggregation by prostacyclin is attenuated after exercise in patients with angina pectoris.
Kishi Y; Ashikaga T; Numano F
Am Heart J; 1992 Feb; 123(2):291-7. PubMed ID: 1736562
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of whole blood platelet aggregation by nicardipine, and synergism with prostacyclin in-vitro.
Greer IA; Walker JJ; McLaren M; Calder AA; Forbes CD
Thromb Res; 1986 Feb; 41(4):509-18. PubMed ID: 3083526
[TBL] [Abstract][Full Text] [Related]
10. Dipyridamole and aspirin in relation to platelet aggregation and vessel wall prostaglandin generation.
Mehta J; Mehta P
J Cardiovasc Pharmacol; 1982; 4(4):688-93. PubMed ID: 6181345
[TBL] [Abstract][Full Text] [Related]
11. The interaction of sodium nitroprusside with human endothelial cells and platelets: nitroprusside and prostacyclin synergistically inhibit platelet function.
Levin RI; Weksler BB; Jaffe EA
Circulation; 1982 Dec; 66(6):1299-307. PubMed ID: 6291803
[TBL] [Abstract][Full Text] [Related]
12. The effects of plasma from IgA nephropathy patients on vascular prostacyclin and platelet cyclic AMP production.
Túri S; Nagy J; Torday C; Havass Z; Bereczky C
Prostaglandins Leukot Essent Fatty Acids; 1989 Jan; 35(1):9-13. PubMed ID: 2538850
[TBL] [Abstract][Full Text] [Related]
13. The cardiovascular and platelet effects of epoprostenol (prostacyclin, PGI2) are unaffected by beta-adrenoceptor blockade in man.
Hassan S; Pickles H; Fish A; Burke C; Warrington S; O'Grady J
Br J Clin Pharmacol; 1982 Sep; 14(3):369-77. PubMed ID: 6127095
[TBL] [Abstract][Full Text] [Related]
14. Lack of association between Doppler velocimetry and synthesis of prostacyclin and thromboxane in umbilical cord vessels from growth retarded fetuses.
Saldeen P; Olofsson P; Marsál K
Acta Obstet Gynecol Scand; 1995 Feb; 74(2):103-8. PubMed ID: 7900504
[TBL] [Abstract][Full Text] [Related]
15. Prostaglandin endoperoxide analogues which are both thromboxane receptor antagonists and prostacyclin mimetics.
Armstrong RA; Jones RL; MacDermot J; Wilson NH
Br J Pharmacol; 1986 Mar; 87(3):543-51. PubMed ID: 3026540
[TBL] [Abstract][Full Text] [Related]
16. Influence of selective thromboxane synthetase blocker CGS-13080 on thromboxane and prostacyclin biosynthesis in whole blood: evidence for synthesis of prostacyclin by leukocytes from platelet-derived endoperoxides.
Mehta J; Mehta P; Lawson DL; Ostrowski N; Brigmon L
J Lab Clin Med; 1985 Sep; 106(3):246-52. PubMed ID: 3928780
[TBL] [Abstract][Full Text] [Related]
17. Heparin counteracts the antiaggregating effect of prostacyclin by potentiating platelet aggregation.
Bertelé V; Roncaglioni MC; Donati MB; de Gaetano G
Thromb Haemost; 1983 Apr; 49(2):81-3. PubMed ID: 6346573
[TBL] [Abstract][Full Text] [Related]
18. Hemodynamic, platelet and clinical responses to prostacyclin in unstable angina pectoris.
Théroux P; Latour JG; Diodati J; Léger-Gauthier C; Morissette D; Bosch X; de Lara J; Waters D
Am J Cardiol; 1990 May; 65(16):1084-9. PubMed ID: 2109927
[TBL] [Abstract][Full Text] [Related]
19. Norepinephrine induces lung vascular prostacyclin synthesis via alpha 1-adrenergic receptors.
Wang HL; Voelkel NF
J Appl Physiol (1985); 1989 Jul; 67(1):330-8. PubMed ID: 2547750
[TBL] [Abstract][Full Text] [Related]
20. Platelet hyperactivity in acute myocardial infarction in man--effects of prostacyclin.
Mueller HS; Rao PS; Greenberg MA; Buttrick PM; Sussman II; Levite HA; Grose RM; Perez-Davila V; Strain JE; Spaet TH
Herz; 1986 Apr; 11(2):116-26. PubMed ID: 2939012
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
